Globestar Therapeutics Corp (GSTC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 09/30
| 09-2015 | 06-2015 | 03-2015 | 12-2014 | 09-2014 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -1,086 | -797 | -530 | -226 | -1,245 |
| Depreciation Amortization | 337 | 308 | 257 | 115 | 722 |
| Accounts receivable | 11 | 4 | 10 | 0 | -5 |
| Other Working Capital | 116 | 216 | 154 | 40 | 201 |
| Other Operating Activity | 219 | 99 | -7 | 2 | 17 |
| Operating Cash Flow | $-403 | $-169 | $-117 | $-69 | $-311 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -14 | -14 | -1 | 0 | -105 |
| Purchase Of Investment | N/A | 0 | N/A | N/A | -35 |
| Investing Cash Flow | $-14 | $-14 | $-1 | $0 | $-140 |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | 421 | 186 | 120 | 71 | 324 |
| Financing Cash Flow | $421 | $186 | $120 | $71 | $324 |
| Beginning Cash Position | 1 | 1 | 1 | 1 | 128 |
| End Cash Position | 6 | 4 | 3 | 3 | 1 |
| Net Cash Flow | $5 | $2 | $2 | $2 | $-127 |
| Free Cash Flow | |||||
| Operating Cash Flow | -403 | -169 | -117 | -69 | -311 |
| Capital Expenditure | -14 | -14 | -1 | 0 | -105 |
| Free Cash Flow | -417 | -184 | -118 | -69 | -416 |